📈 Markets & Finance
Live
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?
Written by David Jagielski for The Motley Fool -> Pfizer has consistently been paying its shareholders a dividend for decades. The company has also carefully raised its dividend, ensuring the payout
Nasdaq News — 3 August 2026
Text:
8
0
0
Pfizer has consistently been paying its shareholders a dividend for decades.
The company has also carefully raised its dividend, ensuring the payouts
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
Indian Shares Marginally Lower In Early Trade
📈 Markets & Finance
Asian Markets Trade Mostly Higher
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Telix Pharmaceuticals Q2 Revenue Climbs Boosted By Precision Medicine Business
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Morning Minute: The Clarity Act Has New Life
